196:. This hardening may affect the bones at the base of the skull or those in the hands, feet, or jaw. This causes ongoing pain and aching within the body parts that are affected. The pain has been described as either a hot electric stabbing pain, an ever-increasing pressure sensation around the bones (especially before electrical storms) or as a constant ache that radiates through several long bones at once. Pain may also occur in the hips, wrists, knees and other joints as they essentially lock up (often becoming very stiff, immobile and sore), mostly when walking up or down staircases, writing for extended periods of time, or during the colder months of the year. Those with the disease tend to have a very characteristic walk medically diagnosed as a 'waddling gait'. This is observed by the broad-based gait with a duck-like waddle to the swing phase, the pelvis drops to the side of the leg being raised, notable forward curvature of the lumbar spine and a marked body swing.
94:
200:
Patients may even require the use of a wheelchair (or additional carer's help with getting dressed, showering, mobility/shopping, preparing meals or lifting heavy items) especially when bedridden or housebound for days or weeks at a time. Flare-ups may be attributed to, or exacerbated by growth spurts, stress, exhaustion, exercise, standing or walking for too long, illness, infection, being accidentally knocked/hurt or injured, after surgery/anaesthetics, cold weather, electrical storms, and sudden changes in barometric pressure.
271:. These functions can be affected by a series of mutations that occur on exon 4, near the carboxyl terminus of the latency associated peptide, or LAP. TGFB1 is expressed as a latent form, a mature form and a B1-LAP. Mutations to R218H affect the association of the B1-LAP and the mature form of TGFB1 by conformational changes to B1-LAP. These mutations can lead to a buildup of mature TGFB1, which accumulates in the mutant R218H fibroblasts. Fibroblasts are a type of cell that creates
70:
211:, which may become enlarged. A loss of vision and/or hearing can occur if bones are adversely affected by the hardening in the skull. Hence proactive specialist check-ups, X-rays, diagnostic tests/scans, and regular blood tests are recommended on an annual basis to monitor the CED bony growth and secondary medical issues that may arise from this condition.
307:
agents, are used in some cases. This form of medication helps in bone strength; however, it can have multiple side effects. In several reports, successful treatment with glucocorticosteroids was described, as certain side effects can benefit a person with CED. This drug helps with pain and fatigue
311:
Alternative treatments such as massage, relaxation techniques (meditation, essential oils, spa baths, music therapy, etc.), gentle stretching, and especially heat therapy have been successfully used to an extent in conjunction with pain medications. A majority of CED patients require some form of
567:
Saito, T., Kinoshita, A., Yoshiura, K. I., Makita, Y., Wakui, K., Honke, K., ... & Taniguchi, N. (2001). Domain-specific mutations of a transforming growth factor (TGF)-β1 latency-associated peptide cause
Camurati-Engelmann disease because of the formation of a constitutively active form of
443:
Whyte, M. P., Totty, W. G., Novack, D. V., Zhang, X., Wenkert, D., & Mumm, S. (2011). Camurati-engelmann disease: Unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand. Journal of Bone and
Mineral
199:
The pain is especially severe during a flare-up, which can be unpredictable, exhausting and last anywhere from a few hours to several weeks. This is a common occurrence for several CED patients, often causing myopathy and extensive sleep deprivation from the chronic, severe and disabling pain.
587:
Janssens, K., ten Dijke, P., Ralston, S. H., Bergmann, C., & Van Hul, W. (2003). Transforming growth factor-β1 mutations in
Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. Journal of Biological Chemistry, 278(9),
282:
Type 2 Camurati-Engelmann
Disease is still speculative, with no distinct evidence to credit its existence. There are many similarities between Type 2 CED and hyperostosis generalisata with striations of the bones (HGS), with some speculating they are two
597:
Nishimura, G., Nishimura, H., Tanaka, Y., Makita, Y., Ikegawa, S., Ghadami, M., ... & Niikawa, N. (2002). Camurati-Engelmann disease type II: Progressive diaphyseal dysplasia with striations of the bones. American
Journal of Medical Genetics, 107(1),
552:
Janssens, K., Gershoni-Baruch, R., Van Hul, E., Brik, R., Guañabens, N., Migone, N., ... & Vanhoenacker, F. (2000). Localisation of the gene causing diaphyseal dysplasia
Camurati-Engelmann to chromosome 19q13. Journal of medical genetics, 37(4),
542:
Ghadami, M., Makita, Y., Yoshida, K., Nishimura, G., Fukushima, Y., Wakui, K., ... & Tomita, H. A. (2000). Genetic mapping of the
Camurati-Engelmann disease locus to chromosome 19q13. 1-q13. 3. The American Journal of Human Genetics, 66(1),
607:
Ayyavoo, A., Derraik, J. G., Cutfield, W. S., & Hofman, P. L. (2014). Elimination of pain and improvement of exercise capacity in
Camurati-Engelmann disease with losartan. The Journal of Clinical Endocrinology & Metabolism, 99(11),
164:
and is considered to be inherited; however, many patients have no previous history of CED within their family. The disease is slowly progressive and, while there is no cure, there is treatment. It is named for M. Camurati and G. Engelmann.
177:) and experience a waddling gait. Other clinical problems associated with the disease include increased fatigue, weakness, muscle spasms, headache, difficulty gaining weight, and delay in puberty. Some patients have an abnormal or absent
254:
between D19S881 to D19S606. TGFB1 protein is encoded by the TGF-B1 gene, which occurs on chromosome 19q13.1-13.3. This protein is responsible for a multitude of functions, one of which includes regulating the function of
279:. This suggests that R218H mutation causes a disassociation between mature-TGFB1 and B1-LAP. Mutations at the LLL12-13ins and Y81H regions decrease the secretion of TGFB1, which leads to intracellular buildup of TGFB1.
718:
703:
577:
Kinoshita, A., Saito, T., Tomita, H. A., Makita, Y., Yoshida, K., Ghadami, M., ... & Fukushima, Y. (2000). Domain-specific mutations in TGFB1 result in
Camurati-Engelmann disease. Nature genetics, 26(1),
482:
Carlson, M. L., Beatty, C. W., Neff, B. A., Link, M. J., & Driscoll, C. L. (2010). Skull base manifestations of
Camurati-Engelmann disease. Archives of Otolaryngology–Head & Neck Surgery, 136(6),
358:
Vanhoenacker, F. M., Janssens, K., Van Hul, W., Gershoni-Baruch, R., Brik, R., & De Schepper, A. M. (2003). Camurati-Engelmann Disease. Acta radiologica, 44(4), 430-434.
1305:
454:
1500:
508:
Nishimura G, Nishimura H, Tanaka Y, et al. (2002). "Camurati–Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones".
312:
analgesics, muscle relaxant, and/or sleep inducing medication to manage the pain, specifically if experiencing frequent or severe flare-ups (e.g. during
1202:
821:
382:"Camurati-Engelman disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment"
338:, used a wheelchair from the age of 13 because of Camurati–Engelmann syndrome. He died on February 10, 2006, at the age of 36 in New York City.
617:
Jadhav, A. T. U. L., & Ghanekar, J. A. I. S. H. R. E. E. (2013). Camurati–Engelmann disease. Indian Journal of Clinical Practice, 24(2).
1298:
1383:
1541:
883:
1521:
1409:
1291:
906:
1536:
250:
Type 1 Camurati-Engelmann Disease is associated with an error occurring in the TGFB1 protein. Affected individuals shared a
1256:
1230:
455:"Camurati-Engelmann disease | Disease | Overview | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program"
1111:
1092:
916:
888:
814:
733:
492:
428:
1268:
1261:
1332:
462:
1235:
807:
1035:
979:
911:
984:
1526:
1355:
787:
636:
1146:
1101:
1487:
1475:
1439:
1365:
1222:
1207:
673:
747:
93:
367:
Mason, J., & Slee, I. (1968). Anaesthesia in Engelmann's disease. Anaesthesia, 23(2), 250-252.
1195:
1132:
1531:
1162:
1083:
630:
304:
1463:
1373:
1315:
1212:
1000:
878:
838:
830:
284:
1434:
1391:
276:
8:
1251:
1182:
1029:
967:
722:
296:
192:
This disease may also cause bones to become abnormally hardened which is referred to as
1169:
727:
661:
406:
381:
107:
173:
Patients with CED complain of chronic bone pain in the legs or arms, muscle weakness (
1125:
1071:
758:
649:
525:
411:
300:
82:
20:
1149:
1060:
1005:
974:
517:
401:
393:
110:
87:
1283:
1190:
1157:
939:
752:
334:
264:
219:
Camurati-Engelmann disease is caused by autosomal dominant mutations in the gene
1458:
1120:
1066:
1020:
934:
926:
843:
268:
193:
763:
712:
643:
1515:
944:
397:
653:
529:
415:
325:
142:
69:
1051:
799:
130:
19:"Engelmann syndrome" redirects here. For the neuro-genetic disorder, see
121:. Patients typically have heavily thickened bones, especially along the
117:. It is also known as progressive diaphyseal dysplasia. It is a form of
1419:
1401:
870:
521:
260:
256:
122:
695:
1047:
898:
852:
380:
Janssens K, Vanhoenacker F, Bonduelle M, et al. (January 2006).
251:
186:
182:
161:
146:
126:
118:
1324:
1010:
782:
272:
174:
150:
114:
1179:
157:
741:
738:
496:
432:
1347:
707:
313:
208:
1470:
568:
TGF-β1.Journal of Biological Chemistry, 276(15), 11469-11472.
379:
241:
220:
204:
178:
138:
134:
642:
Wallace, Stephanie E.; Wilcox, William R. (1 January 1993).
1482:
1428:
961:
637:
GeneReviews/NCBI/NIH/UW entry on Camurati-Engelmann Disease
354:
352:
308:
as well as some correction of radiographic abnormalities.
329:
507:
133:
bones may be thickened so that the passages through the
349:
145:
become narrowed, possibly leading to sensory deficits,
685:
77:
This condition is inherited via autosomal dominance
1313:
295:Camurati–Engelmann disease is somewhat treatable.
1203:Autosomal recessive multiple epiphyseal dysplasia
563:
561:
559:
1513:
556:
375:
373:
1501:intercellular signaling peptides and proteins
1299:
815:
641:
113:that causes characteristic anomalies in the
501:
370:
1410:Autoimmune lymphoproliferative syndrome 1B
1306:
1292:
829:
822:
808:
92:
68:
405:
203:CED may also affect internal organs, the
1514:
907:Spondyloepiphyseal dysplasia congenita
57:Osteopathia hyperostotica scleroticans
53:Progressive diaphyseal dysplasia (PDD)
1333:EDA Hypohidrotic ectodermal dysplasia
1287:
884:Jansen's metaphyseal chondrodysplasia
803:
648:. University of Washington, Seattle.
168:
1231:Rhizomelic chondrodysplasia punctata
129:(called diaphyseal dysplasia). The
917:Otospondylomegaepiphyseal dysplasia
889:Schmid metaphyseal chondrodysplasia
493:Online Mendelian Inheritance in Man
429:Online Mendelian Inheritance in Man
246:Type 2 is not associated with TGFB1
13:
624:
319:
14:
1553:
681:
231:
223:, localized at chromosome 19q13.
49:Camurati–Engelmann syndrome (CES)
1542:Diseases named after discoverers
1257:Short rib – polydactyly syndrome
104:Camurati–Engelmann disease (CED)
1262:Majewski's polydactyly syndrome
611:
601:
591:
581:
571:
546:
536:
1522:Extracellular ligand disorders
486:
476:
447:
437:
422:
361:
16:Rare skeletal genetic disorder
1:
1036:Hereditary multiple exostoses
980:Polyostotic fibrous dysplasia
912:Multiple epiphyseal dysplasia
342:
1537:Autosomal dominant disorders
1269:Léri–Weill dyschondrosteosis
290:
226:
7:
1488:Congenital hypothyroidism 4
1476:Premature ovarian failure 4
1356:Craniofrontonasal dysplasia
386:Journal of Medical Genetics
10:
1558:
1338:Camurati–Engelmann disease
1236:Conradi–Hünermann syndrome
861:Camurati–Engelmann disease
645:Camurati-Engelmann Disease
631:Camurati-Engelmann disease
240:Type 1 is associated with
32:Camurati–Engelmann disease
18:
1464:DHH XY gonadal dysgenesis
1450:
1418:
1400:
1382:
1364:
1346:
1323:
1244:
1223:Chondrodysplasia punctata
1221:
1208:Atelosteogenesis, type II
1178:
1145:
1110:
1091:
1082:
1046:
1019:
999:
953:
925:
897:
869:
851:
837:
773:
689:
633:on Genetic Home Reference
459:rarediseases.info.nih.gov
444:Research, 26(5), 920-933.
81:
76:
67:
36:
31:
1440:Hirschsprung's disease 4
1435:Waardenburg syndrome IVb
985:McCune–Albright syndrome
214:
1133:Thanatophoric dysplasia
398:10.1136/jmg.2005.033522
45:Engelmann syndrome (ES)
1102:Antley–Bixler syndrome
1084:Growth factor receptor
831:Osteochondrodysplasias
41:Engelmann disease (ED)
1374:Tetra-amelia syndrome
1213:Diastrophic dysplasia
879:Metaphyseal dysplasia
287:of the same disease.
285:phenotypic variations
236:There are two forms:
181:, may present with a
297:Glucocorticosteroids
277:extracellular matrix
61:Multiplex infantalis
1252:Fibrochondrogenesis
1030:osteochondromatosis
968:Boomerang dysplasia
1527:Skeletal disorders
1170:Hypochondrogenesis
774:External resources
522:10.1002/ajmg.10079
263:, which decreases
169:Signs and symptoms
108:autosomal dominant
1509:
1508:
1281:
1280:
1277:
1276:
1141:
1140:
1126:Hypochondroplasia
1072:Maffucci syndrome
995:
994:
797:
796:
510:Am. J. Med. Genet
328:, writer for the
305:immunosuppressive
301:anti-inflammatory
160:often appears in
101:
100:
26:Medical condition
21:Angelman syndrome
1549:
1308:
1301:
1294:
1285:
1284:
1183:sulfation defect
1150:collagen disease
1089:
1088:
1061:enchondromatosis
1017:
1016:
1006:chondrodystrophy
1001:Chondrodysplasia
975:Opsismodysplasia
849:
848:
824:
817:
810:
801:
800:
687:
686:
677:
671:
667:
665:
657:
618:
615:
609:
605:
599:
595:
589:
585:
579:
575:
569:
565:
554:
550:
544:
540:
534:
533:
505:
499:
490:
484:
480:
474:
473:
471:
470:
461:. Archived from
451:
445:
441:
435:
426:
420:
419:
409:
377:
368:
365:
359:
356:
332:television show
111:genetic disorder
97:
96:
88:Medical genetics
72:
29:
28:
1557:
1556:
1552:
1551:
1550:
1548:
1547:
1546:
1512:
1511:
1510:
1505:
1446:
1414:
1396:
1378:
1360:
1342:
1319:
1312:
1282:
1273:
1240:
1217:
1191:Achondrogenesis
1174:
1158:Achondrogenesis
1137:
1106:
1078:
1042:
1008:
1004:
991:
954:Other/ungrouped
949:
940:Osteopoikilosis
921:
893:
865:
842:
833:
828:
798:
793:
792:
769:
768:
698:
684:
669:
668:
659:
658:
627:
625:Further reading
622:
621:
616:
612:
606:
602:
596:
592:
586:
582:
576:
572:
566:
557:
551:
547:
541:
537:
506:
502:
491:
487:
481:
477:
468:
466:
453:
452:
448:
442:
438:
427:
423:
378:
371:
366:
362:
357:
350:
345:
335:Ghost Whisperer
322:
320:Notable persons
293:
265:bone resorption
234:
229:
217:
171:
106:is a very rare
91:
27:
24:
17:
12:
11:
5:
1555:
1545:
1544:
1539:
1534:
1529:
1524:
1507:
1506:
1504:
1503:
1498:
1496:
1492:
1491:
1479:
1467:
1454:
1452:
1448:
1447:
1445:
1444:
1443:
1442:
1437:
1424:
1422:
1416:
1415:
1413:
1412:
1406:
1404:
1398:
1397:
1395:
1394:
1388:
1386:
1380:
1379:
1377:
1376:
1370:
1368:
1362:
1361:
1359:
1358:
1352:
1350:
1344:
1343:
1341:
1340:
1335:
1329:
1327:
1321:
1320:
1314:Extracellular
1311:
1310:
1303:
1296:
1288:
1279:
1278:
1275:
1274:
1272:
1271:
1266:
1265:
1264:
1254:
1248:
1246:
1245:Other dwarfism
1242:
1241:
1239:
1238:
1233:
1227:
1225:
1219:
1218:
1216:
1215:
1210:
1205:
1200:
1199:
1198:
1187:
1185:
1176:
1175:
1173:
1172:
1167:
1166:
1165:
1154:
1152:
1143:
1142:
1139:
1138:
1136:
1135:
1130:
1129:
1128:
1121:Achondroplasia
1117:
1115:
1108:
1107:
1105:
1104:
1098:
1096:
1086:
1080:
1079:
1077:
1076:
1075:
1074:
1069:
1067:Ollier disease
1056:
1054:
1044:
1043:
1041:
1040:
1039:
1038:
1025:
1023:
1021:Osteochondroma
1014:
997:
996:
993:
992:
990:
989:
988:
987:
977:
972:
971:
970:
957:
955:
951:
950:
948:
947:
942:
937:
935:Raine syndrome
931:
929:
927:Osteosclerosis
923:
922:
920:
919:
914:
909:
903:
901:
895:
894:
892:
891:
886:
881:
875:
873:
867:
866:
864:
863:
857:
855:
846:
844:osteodystrophy
839:Osteodysplasia
835:
834:
827:
826:
819:
812:
804:
795:
794:
791:
790:
778:
777:
775:
771:
770:
767:
766:
755:
744:
730:
715:
699:
694:
693:
691:
690:Classification
683:
682:External links
680:
679:
678:
670:|website=
639:
634:
626:
623:
620:
619:
610:
600:
590:
580:
570:
555:
545:
535:
500:
485:
475:
446:
436:
421:
369:
360:
347:
346:
344:
341:
340:
339:
321:
318:
292:
289:
269:bone formation
267:and increases
248:
247:
244:
233:
232:Classification
230:
228:
225:
216:
213:
170:
167:
99:
98:
85:
79:
78:
74:
73:
65:
64:
38:
34:
33:
25:
15:
9:
6:
4:
3:
2:
1554:
1543:
1540:
1538:
1535:
1533:
1532:Rare diseases
1530:
1528:
1525:
1523:
1520:
1519:
1517:
1502:
1499:
1497:
1494:
1493:
1489:
1485:
1484:
1480:
1477:
1473:
1472:
1468:
1465:
1461:
1460:
1456:
1455:
1453:
1449:
1441:
1438:
1436:
1433:
1432:
1431:
1430:
1426:
1425:
1423:
1421:
1417:
1411:
1408:
1407:
1405:
1403:
1399:
1393:
1390:
1389:
1387:
1385:
1381:
1375:
1372:
1371:
1369:
1367:
1363:
1357:
1354:
1353:
1351:
1349:
1345:
1339:
1336:
1334:
1331:
1330:
1328:
1326:
1322:
1317:
1309:
1304:
1302:
1297:
1295:
1290:
1289:
1286:
1270:
1267:
1263:
1260:
1259:
1258:
1255:
1253:
1250:
1249:
1247:
1243:
1237:
1234:
1232:
1229:
1228:
1226:
1224:
1220:
1214:
1211:
1209:
1206:
1204:
1201:
1197:
1194:
1193:
1192:
1189:
1188:
1186:
1184:
1181:
1177:
1171:
1168:
1164:
1161:
1160:
1159:
1156:
1155:
1153:
1151:
1148:
1144:
1134:
1131:
1127:
1124:
1123:
1122:
1119:
1118:
1116:
1113:
1109:
1103:
1100:
1099:
1097:
1094:
1090:
1087:
1085:
1081:
1073:
1070:
1068:
1065:
1064:
1063:
1062:
1058:
1057:
1055:
1053:
1049:
1045:
1037:
1034:
1033:
1032:
1031:
1027:
1026:
1024:
1022:
1018:
1015:
1012:
1007:
1002:
998:
986:
983:
982:
981:
978:
976:
973:
969:
966:
965:
964:
963:
959:
958:
956:
952:
946:
945:Osteopetrosis
943:
941:
938:
936:
933:
932:
930:
928:
924:
918:
915:
913:
910:
908:
905:
904:
902:
900:
896:
890:
887:
885:
882:
880:
877:
876:
874:
872:
868:
862:
859:
858:
856:
854:
850:
847:
845:
840:
836:
832:
825:
820:
818:
813:
811:
806:
805:
802:
789:
785:
784:
780:
779:
776:
772:
765:
761:
760:
756:
754:
750:
749:
745:
743:
740:
736:
735:
731:
729:
725:
724:
720:
716:
714:
710:
709:
705:
701:
700:
697:
692:
688:
675:
663:
655:
651:
647:
646:
640:
638:
635:
632:
629:
628:
614:
604:
594:
584:
574:
564:
562:
560:
549:
539:
531:
527:
523:
519:
515:
511:
504:
498:
494:
489:
479:
465:on 2016-04-22
464:
460:
456:
450:
440:
434:
430:
425:
417:
413:
408:
403:
399:
395:
391:
387:
383:
376:
374:
364:
355:
353:
348:
337:
336:
331:
327:
324:
323:
317:
315:
309:
306:
302:
298:
288:
286:
280:
278:
274:
270:
266:
262:
258:
253:
245:
243:
239:
238:
237:
224:
222:
212:
210:
206:
201:
197:
195:
190:
188:
184:
180:
176:
166:
163:
159:
154:
152:
148:
144:
143:blood vessels
140:
136:
132:
128:
124:
120:
116:
112:
109:
105:
95:
89:
86:
84:
80:
75:
71:
66:
62:
58:
54:
50:
46:
42:
39:
35:
30:
22:
1481:
1469:
1457:
1427:
1337:
1059:
1028:
960:
860:
781:
757:
746:
732:
717:
702:
644:
613:
603:
593:
583:
573:
548:
538:
513:
509:
503:
488:
478:
467:. Retrieved
463:the original
458:
449:
439:
424:
389:
385:
363:
333:
326:John Belluso
310:
299:, which are
294:
281:
249:
235:
218:
202:
198:
191:
172:
155:
103:
102:
60:
56:
52:
48:
44:
40:
1052:enchondroma
1009:(including
516:(1): 5–11.
392:(1): 1–11.
261:osteoclasts
257:osteoblasts
137:that carry
37:Other names
1516:Categories
1420:Endothelin
1402:Fas ligand
871:Metaphysis
759:DiseasesDB
608:3978-3982.
588:7718-7724.
469:2016-03-01
343:References
185:, or have
127:long bones
1318:disorders
1048:Chondroma
899:Epiphysis
853:Diaphysis
672:ignored (
662:cite book
291:Treatment
252:haplotype
227:Diagnosis
194:sclerosis
187:scoliosis
183:flat foot
162:childhood
147:blindness
119:dysplasia
83:Specialty
1495:See also
1325:Cytokine
1011:dwarfism
783:Orphanet
654:20301335
553:245-249.
543:143-147.
530:11807860
495:(OMIM):
483:566-575.
431:(OMIM):
416:15894597
275:and the
273:collagen
175:myopathy
151:deafness
115:skeleton
1196:type 1B
1180:SLC26A2
753:D003966
407:2564495
158:disease
125:of the
1392:OFC 11
1348:Ephrin
1316:ligand
1163:type 2
1147:COL2A1
742:606631
739:131300
728:756.59
652:
578:19-20.
528:
497:131300
433:131300
414:
404:
314:winter
209:spleen
139:nerves
123:shafts
90:
1471:BMP15
1451:Other
1112:FGFR3
1093:FGFR2
713:Q78.3
598:5-11.
242:TGFB1
221:TGFB1
215:Cause
205:liver
179:tibia
156:This
149:, or
135:skull
131:skull
1483:TSHB
1429:EDN3
962:FLNB
788:1328
764:4301
748:MeSH
734:OMIM
723:9-CM
674:help
650:PMID
526:PMID
412:PMID
303:and
259:and
207:and
141:and
59:and
1459:DHH
1384:TGF
1366:WNT
719:ICD
704:ICD
518:doi
514:107
402:PMC
394:doi
330:CBS
316:).
51:or
1518::
786::
762::
751::
737::
726::
711::
708:10
666::
664:}}
660:{{
558:^
524:.
512:.
457:.
410:.
400:.
390:43
388:.
384:.
372:^
351:^
189:.
153:.
55:,
47:,
43:,
1490:)
1486:(
1478:)
1474:(
1466:)
1462:(
1307:e
1300:t
1293:v
1114::
1095::
1050:/
1013:)
1003:/
841:/
823:e
816:t
809:v
721:-
706:-
696:D
676:)
656:.
532:.
520::
472:.
418:.
396::
63:.
23:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
